DaVita HealthCare Partners Inc (DVA)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 142.71 | 45.26 | 26.90 | 18.82 | 16.00 | 14.12 | 16.67 | 20.26 | 23.76 | 31.84 | 28.28 | 20.25 | 22.66 | 15.34 | 13.94 | 14.14 | 12.28 | 10.82 | 8.96 | 9.03 |
DaVita HealthCare Partners Inc has demonstrated consistently strong solvency metrics over the reported periods. The company maintained a Debt-to-assets ratio of 0.00, indicating that it funded its assets without relying on debt financing. This implies a low level of financial risk and a healthy balance sheet structure.
Similarly, the Debt-to-capital ratio and Debt-to-equity ratio remained at 0.00 throughout the analyzed periods, reaffirming DaVita's conservative approach to capital structure and financial risk management. These ratios suggest that the company's capital was predominantly sourced from equity rather than debt, reflecting a solid financial position.
The Financial leverage ratio showed fluctuations over time, with a notable increase from December 31, 2020, to December 31, 2021, reaching 22.66. However, the ratio decreased in the following periods, indicating a reduction in financial risk as compared to the peak in 2021. While there was a temporary spike in the leverage ratio in September 30, 2024, reaching 45.26, it is important to monitor this trend to ensure sustainable financial stability.
Overall, DaVita HealthCare Partners Inc's solvency ratios showcase a robust financial foundation, characterized by a prudent debt management strategy and a reliance on equity financing. Investors and stakeholders can be reassured by the company's ability to maintain a sound solvency position throughout the reported periods.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | 4.44 | 4.48 | 4.79 | 4.47 | 4.02 | 3.64 | 3.17 | 3.42 | 3.75 | 4.49 | 5.43 | 5.80 | 6.30 | 6.54 | 6.38 | 5.92 | 7.73 | 2.91 | 3.18 | 3.83 |
DaVita HealthCare Partners Inc's interest coverage ratio provides insight into the company's ability to meet its interest obligations. From March 31, 2020 to December 31, 2024, the interest coverage ratio fluctuated within a range of 2.91 to 7.73. A higher interest coverage ratio indicates a stronger ability to cover interest payments with operating income.
The trend in DaVita's interest coverage ratio shows variability over the period, with some fluctuations. The company experienced a notable increase in interest coverage from December 31, 2020 to March 31, 2021, indicating improved financial health. However, the ratio subsequently decreased before reaching a relatively stable range from June 30, 2021 to December 31, 2024.
Overall, DaVita HealthCare Partners Inc's interest coverage ratio suggests that the company generally has an adequate ability to cover its interest expenses with operating income. Investors and analysts would typically monitor this ratio closely to assess the company's financial risk and stability.